Cefazolin and Benicar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefazolin (cefazolin sodium) and Benicar (olmesartan medoxomil). Common drug interactions include atelectasis among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Cefazolin and Benicar. It is created by eHealthMe based on reports of 50 people who take the same drugs from the FDA, and is updated regularly.

What is Cefazolin?

Cefazolin has active ingredients of cefazolin sodium. It is often used in infection. eHealthMe is studying from 15,157 Cefazolin users. Check the latest studies of Cefazolin.

What is Benicar?

Benicar has active ingredients of olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 36,002 Benicar users. Check the latest studies of Benicar.



On Jul, 12, 2026

50 people who take Cefazolin and Benicar together, and have interactions are studied.

Cefazolin and Benicar drug interactions.

What are the common drug interactions of Cefazolin and Benicar, by gender? *:

female:

  1. Atelectasis (partial or complete collapse of the lung)
  2. Back pain
  3. Blood glucose increased
  4. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  5. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  6. Drug ineffective
  7. Epistaxis (bleed from the nose)
  8. Fatigue (feeling of tiredness)
  9. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  10. Metastases to liver (cancer spreads to liver)

male:

  1. Pneumonia
  2. Dyspnoea (difficult or laboured respiration)
  3. Oedema peripheral (superficial swelling)
  4. Orthopnoea (shortness of breath (dyspnea) when lying down)
  5. Renal failure acute (rapid kidney dysfunction)
  6. Thrombocytopenia (decrease of platelets in blood)
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Asthenia (weakness)
  9. Haemorrhage (bleeding)
  10. Abdominal pain

What are the common drug interactions of Cefazolin and Benicar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  2. Blood cholesterol increased
  3. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  4. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  5. Glaucoma (increased fluid pressure in the eye with vision loss)
  6. Neuropathy peripheral (surface nerve damage)
  7. Purpura senile (skin condition in which areas of the skin develop a purplish or reddish-brown appearance due to bleeding of small blood vessels underneath)
  8. Renal failure (kidney dysfunction)
  9. Resorption bone increased
  10. Tarsal tunnel syndrome (a condition that is caused by compression of the tibial nerve or its associated branches as the nerve)

40-49:

  1. Pain
  2. Renal failure (kidney dysfunction)
  3. Chronic kidney disease
  4. Injury
  5. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  6. Anxiety
  7. Dizziness
  8. Emotional distress
  9. Psychiatric symptom
  10. Psychological trauma

50-59:

  1. Collapse of lung (functional breakdown of lung)
  2. Cystitis (inflammation of the wall of the bladder)
  3. Death
  4. Diabetic nephropathy (diabetic kidney disease)
  5. Drug ineffective
  6. Dyspnoea (difficult or laboured respiration)
  7. Emotional distress
  8. Erythema (redness of the skin)
  9. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  10. Muscle spasms (muscle contraction)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Pneumonia
  3. Cough
  4. Orthopnoea (shortness of breath (dyspnea) when lying down)
  5. Renal failure acute (rapid kidney dysfunction)
  6. Thrombocytopenia (decrease of platelets in blood)
  7. Dysphagia (a condition in which swallowing is difficult or painful)
  8. Fatigue (feeling of tiredness)
  9. Metastases to lung (cancer spreads to lung)
  10. Abdominal pain

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 11 people, 22.00%
  2. Neoplasm Malignant (cancer tumour): 11 people, 22.00%
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints): 7 people, 14.00%
  4. Diabetes: 7 people, 14.00%
  5. Depression: 6 people, 12.00%
  6. Fungal Infection: 6 people, 12.00%
  7. Psoriasis (immune-mediated disease that affects the skin): 6 people, 12.00%
  8. High Blood Cholesterol: 5 people, 10.00%
  9. Pain: 5 people, 10.00%
  10. Indigestion: 5 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cefazolin and Benicar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefazolin and Benicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefazolin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Benicar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefazolin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Benicar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefazolin sodium and olmesartan medoxomil (the active ingredients of Cefazolin and Benicar, respectively), and Cefazolin and Benicar (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: